PABPN1P2

Across TCGA patient cohorts, PABPN1P2 RNA expression is significantly associated with the go_rna of many other GO terms, with 6,979 significant associations in total. STAD shows the largest number of these associations.

The most reproducible PABPN1P2-associated GO terms across cancer lineages are Peptidyl-lysine modification, Regulation of RNA splicing, and RNA methylation. Each is linked with PABPN1P2 in more than 24 cancer types. Because this analysis shows association rather than direction, both PABPN1P2-to-partner and partner-to-PABPN1P2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Peptidyl-lysine modification grouped by PABPN1P2-low versus PABPN1P2-high in STAD.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (PABPN1P2→partner) and Y-score (partner→PABPN1P2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
STAD	Peptidyl-lysine modification →	+0.063	+0.400	<.001	<.001	3	25
STAD	Regulation of RNA splicing →	+0.077	+0.400	<.001	<.001	3	25
STAD	RNA methylation →	+0.059	+0.364	<.001	<.001	3	24
STAD	rRNA metabolic process →	+0.074	+0.425	<.001	<.001	3	24
STAD	Obsolete histone modification →	+0.067	+0.397	<.001	<.001	3	24
STAD	Peptidyl-lysine methylation →	+0.055	+0.361	<.001	<.001	3	24

Each partner links to its Q-omics profile. Showing the 6 strongest of 6,979 associations by consensus.

Peptidyl-lysine modification by PABPN1P2 expression — STAD

Explore this box plot interactively →